{"organizations": [], "uuid": "998c8536bb1464e9e4b3dd53470b0264730318d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/22/globe-newswire-marrone-bio-innovations-to-report-fourth-quarter-and-full-year-2017-financial-results-on-thursday-march-29th-at-200-p-m.html", "country": "US", "domain_rank": 767, "title": "Marrone Bio Innovations to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 29th at 2:00 p.m. Pacific time", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T23:05:00.000+02:00", "replies_count": 0, "uuid": "998c8536bb1464e9e4b3dd53470b0264730318d3"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/22/globe-newswire-marrone-bio-innovations-to-report-fourth-quarter-and-full-year-2017-financial-results-on-thursday-march-29th-at-200-p-m.html", "ord_in_thread": 0, "title": "Marrone Bio Innovations to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 29th at 2:00 p.m. Pacific time", "locations": [], "entities": {"persons": [], "locations": [{"name": "calif.", "sentiment": "none"}, {"name": "davis", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "marrone bio innovations, inc.", "sentiment": "neutral"}, {"name": "marrone bio innovation", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "DAVIS, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), (MBI) a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and water treatment markets, will release financial results for the fourth quarter and full year ended December 31, 2017, after market close on Thursday, March 29, 2018.\nManagement will host an investor conference call at 2:00 p.m. PDT (5:00 p.m. EDT) on March 29, 2018, to discuss Marrone Bio Innovation’s fourth quarter and full year 2017 financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information:\nQ4 2017 Conference Call and Webcast\nDate: Thursday, March 29, 2018\nTime: 2:00 p.m. Pacific time (5:00 p.m. Eastern time)\nU.S. Dial-in: 1-800-239-9838\nInternational Dial-in: 1-323-794-2551\nConference ID: 3589839\nWebcast: http://public.viavid.com/index.php?id=128759\nPlease dial in at least 10 minutes before the start of the call to ensure timely participation.\nA playback of the call will be available through April 29, 2018. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally. Please use the replay pin number 3589839. A webcast will also be available for 30 days on the IR section of the Marrone Bio Innovations website or by clicking here: MBII Q4 2017 Webcast .\nAbout Marrone Bio Innovations\nBIO WITH BITE.\nMarrone Bio Innovations, Inc. (NASDAQ:MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® StargusTM, AmplitudeTM, ZeltoTM and Zequanox®. MBI also distributes Bio-tam 2.0® for Isagro USA and Jet-Ag® for Jet Harvest in most regions of the U.S.\nMarrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers, turf managers and consumers around the globe. For more information, please visit www.marronebio.com .\nMarrone Bio Innovations Forward Looking Statements\nThis press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding sales of the Company’s products, the potential benefits of the Company’s products, and MBI’s efforts with respect to expansion of its product labels in international markets. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company's control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company’s products, any difficulty in marketing MBI’s products in global markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, and adverse decisions by regulatory agencies and other relevant third parties. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.\nMarrone Bio Innovations Contacts:\nPam Marrone, CEO and Founder\nJim Boyd, CFO\nTelephone: +1 (530) 750-2800\nEmail: Info@marronebio.com\nInvestor Relations:\nGreg Falesnik\nManaging Director\nMZ Group – MZ North America\nMain: 949-385-6449\nMBII@mzgroup.us\nwww.mzgroup.us\nSource:Marrone Bio Innovations", "external_links": ["http://public.viavid.com/index.php?id=128759", "https://www.globenewswire.com/Tracker?data=8IyTCYDUiro1Wi3VJb3-PvZNvBG4utTaozaXE0rgN-UCBPenIjmakGIGhw3QGuJq_nf_QkuVdLx1eC0-zaSZK7Mf-FHcZDtsYTxb1zPj148=", "https://www.globenewswire.com/Tracker?data=wQG2j1pLqvADsrpRn-jxKWfOOOUrDP7evyNW3XSl-MbZvT62urZWomVy8-BciYtFWZHXyj05d7RrKiuWTOgPuA==", "https://www.globenewswire.com/Tracker?data=2RiA8_eRk3sEk6eLeTQ1JVT0V3ECNcxW2BVs_RgZNgH5tQV7gI1gSkx3_iXfooFtEOQsT0hJg2uHHEAL9TaAZB_lLlsl5U8nGJ_Q7BdtEqcVavGpxG02aJmspJhhjyKi", "https://www.globenewswire.com/NewsRoom/AttachmentNg/53c602dc-d94d-4fb2-b0ed-f5a9c22f2832", "https://www.globenewswire.com/Tracker?data=xiS3ak3xMSfH2uRDCrxvItVb5mvwxG68rUYgmes_tFklhGoSuGbMm4sHMlv_UmW9dzuVYMPN37NfJ_0zW55fJwtG8uNElAhhQi3UaJCHyD9LCEjAPMmSXqbfowAXjtbxbZpyyP1dtf_i38V6Pai7Sg==", "https://www.globenewswire.com/Tracker?data=1w2tYshhu11HulxucupH5zCYL_KFeRmiAJsBmdaGZDmGuYiTPwmTI3JT_cWwZm2xk5ecEuRW0HQYHoOv9vtdJ3UjNhAY8tbM1-yLzJunrc0=", "https://www.globenewswire.com/Tracker?data=GCXtmTmBQmuJiQ6MlPRzf7gA0JyLc1HrAuC8O5WYiMUu_km-FtlFCi35fTOJkE3lk3G60efylZn2jDnTnaW-rQ=="], "published": "2018-03-22T23:05:00.000+02:00", "crawled": "2018-03-22T22:46:53.000+02:00", "highlightTitle": ""}